Procardia (Nifedipine): Contributing Factor to Implant Failure?
I placed an implant 7 years ago in #14 site. Recently, I had to remove this implant as it had failed. The patient began taking Procardia [nifedipine] 3 years ago and had the accompanying gingival hyperplasia.
Does anyone have any information as to whether Procardia is a contributing factor to implant failure? The gingival hyperplasia resulted in the gingival crest being almost level with the occlusal surface of #14’s crown which made cleaning this area extremely difficult if not impossible. I want to place a new implant into this site down the road, but wonder if I should, as this patient does not plan on getting off of Procardia. Any insight or recommendations?
1 Comments on Procardia (Nifedipine): Contributing Factor to Implant Failure?
New comments are currently closed for this post.
drj
10/1/2015
I had a patient begin to develop peri-implantitis with crerstal bone loss down to the second threads after beginning Dilantin Tx. The implants and tissue response were normal for the five years prior to the Dilantin. The Dilantin was d/c 'ed and the sx resolved after one month. It is a single case example but has me thinking about the clinical down side of gingival hyperplasia inducing Rx when Tx planning.
